Re-Discussion on Linearity Between Fibrosis Stages and Mortality Risk in Non-Alcoholic Fatty Liver Disease Patients

Hepatology - United States
doi 10.1002/hep.29390
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Experimental Hepatology
Hepatology
2012English

Cardiovascular Risk Factors in Patients With Non Alcoholic Fatty Liver Disease

Journal of Evolution of Medical and Dental sciences
2013English

Prevalence of Non-Alcoholic Fatty Liver Disease and Risk Factors for Advanced Fibrosis and Mortality in the United States

PLoS ONE
Multidisciplinary
2017English

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2018English

Sarcopenia Is Associated With Severe Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Current Modalities of Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Translational Hepatology
2017English

The Risk of Atrial Fibrillation in Patients With Non-Alcoholic Fatty Liver Disease and a High Hepatic Fibrosis Index

Scientific Reports
Multidisciplinary
2020English

Relationship Between Non-Alcoholic Fatty Liver Disease and Thyroid Dysfunction

Internal Medicine
Internal MedicineMedicine
2016English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy